FDA Proposes Including Vitamin D With Calcium In Osteoporosis Claims
This article was originally published in The Tan Sheet
Executive Summary
FDA's proposed simplification of the calcium and osteoporosis health claim could encourage more firms in the industry to use the claim in product labeling, the agency states in a proposed rule published in the Jan. 5 Federal Register